InspireMD
NSPR
45 hedge funds and large institutions have $41.2M invested in InspireMD in 2025 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.
50% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 8
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
10% more funds holding
Funds holding: 41 → 45 (+4)
0.2% more ownership
Funds ownership: 54.48% → 54.68% (+0.2%)
25% less capital invested
Capital invested by funds: $54.8M → $41.2M (-$13.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
50% less call options, than puts
Call options by funds: $9K | Put options by funds: $18K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$2.08M |
| 2 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$1.44M |
| 3 |
ISL
Ingalls & Snyder LLC
New York
|
+$332K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$325K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$238K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$2.22M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$669K |
| 3 |
HA
Huntleigh Advisors
St. Louis,
Missouri
|
-$636K |
| 4 |
IIM
Ironwood Investment Management
Boston,
Massachusetts
|
-$148K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
-$131K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SS
51
SBI Securities
Tokyo,
Japan
| – | -$554 | -230 | Closed |
|
|
KHC
52
Koesten Hirschmann & Crabtree
Overland Park,
Kansas
| – | -$5 | -2 | Closed |
|
53
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$375 | +180 | New |
|
NSPR Hedge Fund Activity: Q4 2025 in Review
45 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in InspireMD (NSPR) for Q4 2025, worth a combined $41.2M — down 25% from $54.8M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new NSPR positions and 8 closed out — a net gain of 4 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was OrbiMed, adding an estimated $2.08M. The largest seller was Ghisallo Capital Management, exiting entirely with an estimated $2.22M sold.
- 45 institutional investors held InspireMD (NSPR) as of Q4 2025, up from 41 in Q3 2025.
- Funds reported $41.2M of InspireMD stock for Q4 2025, down 25% quarter-over-quarter.
- 12 funds opened new InspireMD positions in Q4 2025 and 8 closed out, a net change of +4 holders.
- The largest InspireMD buyer in Q4 2025 was OrbiMed, an estimated $2.08M added.
- The largest InspireMD seller in Q4 2025 was Ghisallo Capital Management, an estimated $2.22M sold.
Based on aggregated 13F filings for Q4 2025.